1991
DOI: 10.1016/0006-8993(91)90752-h
|View full text |Cite
|
Sign up to set email alerts
|

β-Adrenergic receptor distribution in human and rat hippocampal formation: marked species differences

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
22
0

Year Published

1993
1993
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(23 citation statements)
references
References 25 publications
1
22
0
Order By: Relevance
“…Vulnerability of the hippocampus can be expected to occupy a fairly wide developmental window, given the fact that neurogenesis and synaptic remodeling continue into adolescence in this region (McWilliams and Lynch, 1983;Altman and Bayer, 1990). It is of particular importance that the human hippocampus has a high concentration of ␤ 2 ARs, the specific subtype mediating the effects of terbutaline (Duncan et al, 1991).…”
Section: Discussionmentioning
confidence: 99%
“…Vulnerability of the hippocampus can be expected to occupy a fairly wide developmental window, given the fact that neurogenesis and synaptic remodeling continue into adolescence in this region (McWilliams and Lynch, 1983;Altman and Bayer, 1990). It is of particular importance that the human hippocampus has a high concentration of ␤ 2 ARs, the specific subtype mediating the effects of terbutaline (Duncan et al, 1991).…”
Section: Discussionmentioning
confidence: 99%
“…Nicholas et al (1993) reported that both ␤1-and ␤2-ARs reside in the rat hippocampus, with ␤1-AR mRNA a light labeling and ␤2-AR mRNA a moderate labeling in the CA1 stratum pyramidale. Duncan et al (1991) reported that the ventral subiculum and entorhinal cortex in the rat have the highest density of ␤-AR. Jurgens et al (2005) reported that ␤1-AR labeling was present on the pyramidal cells in the hippocampus and the heaviest labeling was observed along the plasma membrane and within the cytoplasm of cells in the CA3 region.…”
Section: Discussionmentioning
confidence: 99%
“…Obviously, the discrepancies in the basal binding could also be due to differences between both species in the diverse contribution of the multiple types of GPCR to the basal activity and their anatomical distribution. That is the case with some receptors such as the luteinizing-hormone-releasing receptor, adenosine A1, a1 and b adrenoceptors, dopamine D2, 5-HT 1A and cholecystokinin-octapeptide among others which have been described as having different densities in human and rat SNC Fastbom et al, 1987;Reubi et al, 1987;Kohler and Chan-Palay, 1988;Kohler et al, 1991;Duncan et al, 1991Duncan et al, , 1998Little et al, 1992;Berkowitz et al, 1994). However, it is also possible that there are differences in the efficiency of the coupling and/or the effector proteins (González-Maeso et al, 2002).…”
Section: Discussionmentioning
confidence: 92%
“…Further studies are necessary to clarify the efficiency of selective compounds for GAL receptors. The rat has been used as an experimental model for neuropharmacological research of the galaninergic system and numerous ligands for neurotransmitter receptors, including GAL, present similar binding affinities and pharmacological selectivity in both rats and humans Duncan et al, 1991;Branchek et al, 2000). Previous studies had also shown the existence of substantial differences between these two species regarding the regional distribution of neurotransmitter receptors in the brain (Kohler and Chan-Palay, 1988;Duncan et al, 1991Duncan et al, , 1998Little et al, 1992).…”
Section: Discussionmentioning
confidence: 98%